AVEANNA HEALTHCARE HOLDINGS INC (AVAH)
Health Care · Home Healthcare Services · NASDAQ
Aveanna Healthcare is a leading provider of comprehensive home-based healthcare services, focusing on specialized clinical and supportive care for patients.
What AVEANNA HEALTHCARE HOLDINGS INC does
Aveanna Healthcare Holdings provides specialized home-based healthcare services, including clinical, rehabilitative, and supportive care. Its service offerings span private duty nursing, home health and hospice care, and the provision of durable medical equipment.
Themes: home healthcare, hospice services, private duty nursing, value-based care
Fundamentals
- Price$13.16 as of 2026-08-21 close
- Market cap$2.9B as of 2026-08-21
- 1-year return+86.9% 2025-08-21 close $7.04 → 2026-08-21 close $13.16
- P/E9.40 as of 2026-08-24
- Net margin+10.4% as of 2026-08-24
- Gross margin+33.0% as of 2026-08-24
- ROE+157.8% as of 2026-08-24
- Debt / equity6.07 as of 2026-08-24
- Revenue growth (YoY)+20.5% as of 2026-08-24
- Revenue CAGR (3y)+8.0% SEC XBRL
- Beta1.96 as of 2026-08-24
- Last reported earnings2026-08-13 SEC EDGAR Form 8-K (Item 2.02)
How AVAH compares in its sector
- price-to-earnings ratiobottom 25% 203 covered Health Care peers, as of 2026-08-24
- net profit margintop 25% 504 covered Health Care peers, as of 2026-08-24
- operating margintop 25% 504 covered Health Care peers, as of 2026-08-24
- gross marginbottom 25% 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 10% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
AVAH is not currently in any published Top 10 list. Its scores are below.
Long-term score
Not scored for the long-term list: no shareholder return data.
Short-term score
49.7 #811 of 1,704 scored · #140 of 240 in Health Care
Volume and participation 92nd: trading volume is running unusually high — about 3.2× its 30-day average, a sign of heightened interest; trend 82nd: it is trading 38.2% above its 50-day average, the short-term trend line; weakest is setup 24th: day-to-day price swings are unusually wide versus its own recent history (wider than about 99% of the past ~6 months). Its score is docked 10 points for overextended (RSI above 75 or stochastic above 90).
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
How AVEANNA HEALTHCARE HOLDINGS INC looks technically
AVEANNA HEALTHCARE HOLDINGS INC (AVAH) is trading 59.5% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 21 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 33, with buyers in control. Momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 78, in overbought territory (above 70). MACD, a trend-momentum gauge, turned bullish about 7 trading days ago (its momentum flipped positive). It made a new 20-day high about 3 trading days ago. It is 3.3% below its all-time high. Trading volume is running unusually high — about 3.2× its 30-day average, a sign of heightened interest.
Trend
8
| Distance from the 200-day | it is trading 59.5% above its 200-day average, the long-term trend line — a longer-term uptrend | +59.5% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $9.52 | $9.52 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $8.25 | $8.25 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 9 calendar days ago — the swings before that are what the structure reading is measured on | 9 sessions |
| Wave structure | its recent swings can be read as a completed three-part downward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes below 8.755. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible three-wave downward correction, complete (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 21 trading days ago — a "golden cross", a bullish long-term signal | 21 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 33, with buyers in control | 33.1 |
Momentum
3
| 14-day RSI | momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 78, in overbought territory (above 70) | 78.5 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($8.76 to $13.61) — its "stochastic" reading is 91 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 90.8 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 7 trading days ago (its momentum flipped positive) | 7 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $13.61 | $13.61 |
|---|---|---|
| From the 52-week high | it is 3.3% below its 52-week high (its highest price of the past year) | -3.3% |
| Above the 52-week low | it is 121.9% above its 52-week low (its lowest price of the past year) | +121.9% |
| Below the 52-week high | it is 3.3% below its highest point of the past year | 3.3% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day high about 3 trading days ago | 3 sessions |
| All-time high | its highest closing price on record is $13.61 (set on 2026-08-21) | $13.61 |
| Given back of the 52-week move | over the past year its closes ranged ($6.22 to $13.16), and it has given back essentially none of its rise from last year’s low — 0% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $8.65 to $8.87. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.0% |
| From the all-time high | it is 3.3% below its all-time high | -3.3% |
| Nearest price level | it is trading 23.9% above a support level at $10.01 — a price it turned at three times since 2025-10-29, most recently on 2026-07-29. Since 2024-08-21 it has 12 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -23.9% |
| All-time low | its lowest closing price on record is $0.6664 (set on 2022-12-30) | $0.6664 |
| Above the all-time low | it is 1874.8% above its all-time low | +1,875% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 99% of the past ~6 months) | 99th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.6173 between its high and its low — about 4.7% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.6173 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $7.44 and $13.68 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $7.44 – $10.56 – $13.68 |
| Typical daily range (% of price) | its price moves about 4.7% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.7% |
| Stretch from the 200-day average | it is trading 8.0 daily ranges above its 200-day average price (59.5% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 8.0 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is running unusually high — about 3.2× its 30-day average, a sign of heightened interest | 3.20× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 18.2% since the prior reading | +18.2% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
3
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|---|---|
| Since a bullish engulfing | today it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | today |
| Since a bearish engulfing | 8 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 8 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 1.5% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -1.5% |
|---|---|---|
| Open gap | it gapped 5.5% above the previous close 5 sessions ago and has not traded back through the level it left behind at 11.29 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +5.5% |
| Gap filled | a 2.2% gap up opened on 2026-08-03 has been "filled" 13 sessions ago — price traded back through the level the gap left behind, and it took 1 session to close | 13 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 32.8 percentage points (the stock gained 35.1% while the market gained 2.3%) | +32.8% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 68.5 percentage points (the stock gained 71.6% while the market gained 3.1%) | +68.5% |
| vs market, 6 months | over the past 6 months this stock beat the market by 68.2 percentage points (the stock gained 79.3% while the market gained 11.1%) | +68.2% |
| vs market, 12 months | over the past 12 months this stock beat the market by 66.5 percentage points (the stock gained 86.9% while the market gained 20.5%) | +66.5% |
Signal agreement
2
| Bullish technical signals | 7 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 7 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: its RSI momentum gauge is overbought (a stretched reading), near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 48% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 5.4% of the share price. | +47.9% |
|---|
Volume-weighted price
1
| Vs this year’s average price paid | the price is 52% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $8.67 — a volume-weighted average of daily closes over 155 sessions, not a true tick-by-tick VWAP. | +51.7% |
|---|
Price levels it has turned at before
AVAH last closed at $13.16 on 2026-08-21. Since 2024-08-21 it has turned at 12 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $10.01 | Support | 23.9% below the last close | turned there three times · 2025-10-29 to 2026-07-29 |
| $9.00 | Support | 31.6% below the last close | turned there three times · 2025-10-01 to 2026-07-23 |
| $8.72 | Support | 33.8% below the last close | turned there four times · 2025-09-18 to 2026-08-12 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part downward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes below $8.76.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This reading has stood for 3 trading days, since 2026-08-19.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Overbought (14-day RSI above 70) · Unusually heavy trading volume · Broke out to a new 20-day high · Broke out to a new 20-day high on heavy volume | Learn: moving average · golden cross · adx · rsi · macd · breakout · all time high · volume and relative volume
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.73 mean, 1=Strong Buy…5=Strong Sell) — 10 analysts
- Mean price target$12.35 range $8.00 – $16.00; median $13.00
Analyst estimates, as of 2026-08-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for AVAH
- Consensus EPS estimate$0.2032 next reporting period, as of 2026-08-17
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Substantial indebtedness which limits financial flexibility and reaction to market changes.","Heavy reliance on government reimbursement programs (Medicare/Medicaid) and potential for adverse rate changes or payment model shifts.","Intense competition for qualified healthcare personnel and in the broader home healthcare market."]
What changed in the latest 10-Q
AI-assisted comparison of AVAH's 10-Q filed 2026-05-14 against the prior one filed 2025-11-06.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing references fiscal year ended January 3, 2026 in the 10-K cross-reference (older filing referenced December 28, 2024)
- Newer filing includes segment revenue table for three-month period ended April 4, 2026 with consolidated revenue of $647,915 thousand
- Newer filing includes comparison three-month period ended March 29, 2025 with consolidated revenue of $559,224 thousand
- Newer filing states 'Fiscal year 2026' refers to 52-week fiscal year ending January 2, 2027
- Newer filing states 'first quarter of 2026' refers to 13-week fiscal quarter ended April 4, 2026
- Newer filing uses terminology 'PDN Services' (capitalized with 'Services') in multiple instances
- Newer filing uses terminology 'Therapy Services' (capitalized with 'Services') in multiple instances
- Newer filing uses terminology 'HH Services' (capitalized with 'Services') in multiple instances
- Newer filing describes PDN services as provided to 'medically complex' patients
- Newer filing includes text about hospice services involving 'supportive philosophy' and being 'a positive, empowering form of care'
- Removed:
- Older filing included nine-month period revenue tables for ended September 27, 2025 and September 28, 2024
- Older filing stated 'Fiscal year 2024' refers to 52-week fiscal year ended December 28, 2024
- Older filing included definitions for 'third quarter of 2025' and 'third quarter of 2024'
- Older filing included definitions for 'first nine months of 2025' and 'first nine months of 2024'
- Older filing used terminology 'PDN' services and 'pediatric therapy services' (lower case descriptors)
- Older filing used terminology 'home health services' (lower case descriptor)
- Older filing described PDN services as provided to 'medically fragile' patients
- Older filing stated 'We also help our patients manage their medications' in HHH Segment description
- Reworded:
- Older filing referenced 'Risk Factors' as 'included under Part II, Item 1A below'; newer filing removed this location-specific reference
- Older filing used 'Our PDN patients' and 'our PDN services' (possessive); newer filing uses 'PDN Services Patients' and 'PDN Services' (noun forms)
- Older filing stated 'Our PDN services involve'; newer filing states 'PDN Services involve' (depersonalization of service description)
- Older filing stated 'Through our pediatric therapy services'; newer filing states 'Therapy Services provide' (simplified phrasing)
- Older filing stated 'Our home health services involve'; newer filing states 'HH Services involve' (use of abbreviation and depersonalization)
- Notes:
- The two filings compare different fiscal quarters (Q1 2026 vs Q3 2025), so revenue tables and period references are fundamentally different periods rather than comparable restatements
- Textual changes in PDS and HHH segment descriptions appear to reflect revised language rather than substantive operational changes; 'medically complex' vs 'medically fragile' may be terminology preference rather than factual operational difference
- The newer filing appears truncated at the end of the HHH Segment section, limiting full comparison of that segment's description
Risk Factors
- Added:
- Reference to 'pending acquisition of Family First Holding, LLC' added to acquisition risk factor (newer filing, filed 2026-05-14)
- Addition of 'Deferred income taxes' ($137,140 thousand) as a specific long-term asset line item in the balance sheet (newer filing, filed 2026-05-14)
- Removed:
- Reference to 'proposed rule' for home health prospective payment system removed; changed to 'final rule' (older filing, filed 2025-11-06 used 'proposed')
- 'Stockholders' Deficit' caption changed to 'Stockholders' Equity' in balance sheet section heading (older filing, filed 2025-11-06 showed deficit)
- Removal of specific 'Deferred income taxes' line item ($6,501 thousand) from long-term liabilities in older balance sheet (it now appears as long-term asset in newer filing)
- Reworded:
- Home health prospective payment system described as 'final rule' in newer filing (filed 2026-05-14) vs. 'proposed rule' in older filing (filed 2025-11-06)
- 10-K filing date updated from 'March 13, 2025' in older filing to 'March 19, 2026' in newer filing
- Item numbers in table of contents changed from page 43 to page 32 for Items 1A through 6 and Signatures moved from page 45 to page 33
- Notes:
- Balance sheet dates differ between filings (April 4, 2026 vs. September 27, 2025 for newer and older respectively), making line-item comparisons reflect both timing differences and operational changes
- The consolidated balance sheets contain different fiscal period end dates, so balance sheet changes reflect both period-to-period movements and potentially different acquisition/integration status
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 21 open-market sales by insiders in the last 90 days.
- Last 90 days0 buys · 21 sells ($215M) — 3 selling insiders
- Last 180 days0 buys · 22 sells ($216M) — 4 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-30. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about AVAH's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding AVAH as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 8,609,544
- Reported value $55,445,465
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 2 increased, 3 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
AVAH had 4,418,916 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
AVAH had 2.02% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.37 days to cover at the same settlement.
- Reported short interest (shares) 4,418,916
- Short interest (% of shares outstanding) 2.02%
- Prior settlement (shares) 4,517,108
- Reported change -2.17%
- Days to cover (reported) 2.37
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Amedisys (AMED)
- Addus HomeCare (ADUS)
- The Pennant Group (PNTG)
- Gentiva Health Services
- LHC Group (acquired by Optum)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare AVAH vs…
AVAH ranks in…
Frequently asked questions
What does AVEANNA HEALTHCARE HOLDINGS INC (AVAH) do?
Aveanna Healthcare Holdings provides specialized home-based healthcare services, including clinical, rehabilitative, and supportive care. Its service offerings span private duty nursing, home health and hospice care, and the provision of durable medical equipment.
What sector is AVEANNA HEALTHCARE HOLDINGS INC (AVAH) in?
AVEANNA HEALTHCARE HOLDINGS INC (AVAH) is classified in the Health Care sector. Its industry is Home Healthcare Services. It trades on NASDAQ.
Who are AVEANNA HEALTHCARE HOLDINGS INC's (AVAH) competitors?
Notable peers of AVEANNA HEALTHCARE HOLDINGS INC (AVAH) include Amedisys, Addus HomeCare, The Pennant Group, Gentiva Health Services and LHC Group (acquired by Optum). This peer set is informational only — not financial advice.
Is AVEANNA HEALTHCARE HOLDINGS INC (AVAH) overbought or oversold right now?
AVEANNA HEALTHCARE HOLDINGS INC (AVAH) is currently in overbought territory (its 14-day RSI is 78, above 70) (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on AVAH come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.